Exact Sciences (EXAS)
(Delayed Data from NSDQ)
$49.84 USD
-4.24 (-7.84%)
Updated May 24, 2024 04:00 PM ET
After-Market: $49.85 +0.01 (0.02%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Exact Sciences Corporation [EXAS]
Reports for Purchase
Showing records 141 - 160 ( 364 total )
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Lowering PT from $18 to $7 After Model Rebuild - Slim Chance of USPSTF Opinion Change - Out Year Adoption More Questionable - Little Margin for Error
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
USPSTF Draft Not Exactly a Ringing Endorsement for Cologuard
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
USPSTF "Alternative" Designation Not as Favorable as Anticipated
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
USPSTF Draft Not Exactly a Ringing Endorsement for Cologuard - Perhaps It''s Just Enough - We''d Be Buyers Below Our Price Target of $18
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Healthcare - 3Q 2015: Quarterly Medical Technology Trading - Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
2Q/3Q Inline with Preannouncement; Stock Offering Announced
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Relatively Uneventful 2Q15 Call - 3Q Guidance Reiterated - GMs - Opex Better
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Medical Technology: 2Q15 Quarterly Trading - Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
1Q15 Recap - Solid Improvement Over 4Q Call - 2Q Vol. Guidance Is Enough - Tone Confident - Positive Summer Catalysts On Track - Maintain LT NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Pre-Call Summary: Test Volume In Line with Street View - Below Wedbush Street-High Model - Doc Adds Look Better - No Guidance - Opex Fine - Maintain N
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of May 4th
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
1Q15 Preview - Expecting Cologuard Volumes to Easily Top 1Q Guide - Sales Could be Noisy - 2Q Volume Trajectory Key - Warming Slightly - Maintain N
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Healthcare -1Q 2015: Quarterly Medical Technology Trading - Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.